Iberogast Advance (Bitter Candytuft Fresh Plant Extract, Matricaria Liquid Extract, Menthae Piperitae Folium, Melissae)

• Iberogast is used to alleviate symptoms associated with functional gastrointestinal disorders.
• Functional dyspepsia: reduces upper abdominal pain, early satiety and bloating, improving meal tolerance.
• Irritable bowel syndrome: eases abdominal cramping and irregular bowel movements, supporting regularity and comfort.
• Gastrointestinal discomfort: mitigates nonspecific stomach upset and indigestion, contributing to overall digestive well‑being.

• The exact mechanism of Iberogast is not fully defined. It is believed that the combination of bitter candytuft, chamomile, peppermint and lemon balm extracts exerts spasmolytic, anti‑inflammatory and pro‑kinetic actions on the gastrointestinal tract. These effects may modulate smooth‑muscle activity, reduce visceral hypersensitivity and influence gastric emptying, contributing to symptom relief. Additionally, the phytochemicals may interact with enteric nervous system receptors, further supporting coordinated motility.

Iberogast may cause adverse reactions, which are generally mild but can include more serious events in rare cases.

Common Side Effects

• Mild gastrointestinal upset: transient nausea or mild abdominal discomfort.
• Taste alteration: temporary bitter or minty aftertaste.
• Headache: occasional mild headache.
• Allergic skin reaction: localized rash or itching.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction with difficulty breathing, swelling, or hives.
• Severe liver injury: rare cases of hepatitis or elevated liver enzymes.
• Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

When considering Iberogast, several precautions should be observed to ensure safe use.

• Pregnancy: consult a healthcare professional before use, as safety data are limited.
• Breastfeeding: discuss potential risks with a physician.
• Concurrent gastrointestinal disease: use under medical supervision if severe conditions such as ulcer disease are present.
• Allergy history: avoid if known hypersensitivity to any of the plant extracts.
• Drug interactions: review concomitant medications with a pharmacist or physician.
• Store at ambient temperature: keep the bottle tightly closed, protect from light and moisture, and store below 25 °C.

Iberogast can interact with other medicines; awareness of the interaction level helps manage risk.

Major Interactions (Avoid)

• Cytochrome P450 substrates: potential alteration of metabolism for drugs heavily reliant on CYP enzymes.
• Anticoagulants: possible increased bleeding risk; monitor coagulation parameters.

Moderate Interactions (Monitor Closely)

• Anticholinergic agents: additive effects on gastrointestinal motility may occur.
• Proton pump inhibitors: may reduce the efficacy of Iberogast's pro‑kinetic action.
• Herbal supplements with similar constituents: risk of cumulative effects.